The brain 5-HT4 receptor binding is down-regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration

J Neurochem. 2009 Jun;109(5):1363-74. doi: 10.1111/j.1471-4159.2009.06050.x. Epub 2009 Mar 23.

Abstract

The 5-hydroxytryptamine (5-HT(4)) receptor may be implicated in depression and is a new potential target for antidepressant treatment. We have investigated the brain 5-HT(4) receptor [(3)H]SB207145 binding in the Flinders Sensitive Line rat depression model by quantitative receptor autoradiography, and related this to 5-HT transporter (S)-[N-methyl-(3)H]citalopram binding. We also determined the regulation of 5-HT(4) receptor binding by 1, 14, and 21 days of paroxetine administration and subchronic 5-HT depletion, and compared this with changes in 5-HT(2A) receptor [(3)H]MDL100907 binding. In the Flinders Sensitive Line, the 5-HT(4) receptor and 5-HT transporter binding were decreased in the dorsal and ventral hippocampus, and the changes in binding were directly correlated within the dorsal hippocampus. Chronic but not acute paroxetine administration caused a 16-47% down-regulation of 5-HT(4) receptor binding in all regions evaluated including the basal ganglia and hippocampus, while 5-HT depletion increased the 5-HT(4) receptor binding in the dorsal hippocampus, hypothalamus, and lateral globus pallidus. In comparison, the 5-HT(2A) receptor binding was decreased in the frontal and cingulate cortices after chronic paroxetine administration, and markedly reduced in several regions after 5-HT depletion. Thus, the 5-HT(4) receptor binding was decreased in the Flinders Sensitive Line depression model and in response to chronic paroxetine administration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antidepressive Agents, Second-Generation / administration & dosage*
  • Autoradiography / methods
  • Brain / drug effects
  • Brain / metabolism*
  • Brain / pathology
  • Citalopram / metabolism
  • Depression* / drug therapy
  • Depression* / genetics
  • Depression* / pathology
  • Disease Models, Animal
  • Fenclonine / pharmacology
  • Fenfluramine / pharmacology
  • Fluorobenzenes / metabolism
  • Freezing Reaction, Cataleptic / drug effects
  • Male
  • Paroxetine / administration & dosage*
  • Piperidines / metabolism
  • Protein Binding / drug effects
  • Rats
  • Rats, Inbred Strains
  • Rats, Sprague-Dawley
  • Receptors, Serotonin, 5-HT4 / metabolism*
  • Selective Serotonin Reuptake Inhibitors / pharmacology
  • Serotonin / deficiency
  • Serotonin Antagonists / pharmacology
  • Serotonin Plasma Membrane Transport Proteins / metabolism
  • Swimming
  • Time Factors
  • Tritium / metabolism

Substances

  • Antidepressive Agents, Second-Generation
  • Fluorobenzenes
  • Piperidines
  • SB 207145
  • Serotonin Antagonists
  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin Uptake Inhibitors
  • Citalopram
  • Tritium
  • Receptors, Serotonin, 5-HT4
  • Fenfluramine
  • Serotonin
  • Paroxetine
  • volinanserin
  • Fenclonine